Breedon Group Plc

M&A Activity • Dec 1, 2020

National Storage Mechanism | Additional information

RNS Number : 0748H

Breedon Group PLC

01 December 2020

NEWS RELEASE

1 December 2020                                                                                          

Breedon Group plc

("Breedon" or the "Company")

Update on the acquisition of certain assets and operations

of CEMEX in the UK

Breedon, a leading construction materials group in Great Britain and Ireland, notes the announcement today by the Competition and Markets Authority that it has accepted Breedon's undertakings in lieu of a reference to a Phase 2 investigation in respect of its acquisition of certain assets from Cemex Investments Limited. We now expect the disposal of certain assets to Tillicoultry Quarries Limited to complete shortly.

- ends -

Information on Breedon Group

Breedon Group plc is a leading construction materials group in Great Britain and Ireland. It operates two cement plants and an extensive network of quarries, asphalt plants and ready-mixed concrete plants, together with slate production, concrete and clay products manufacturing, contract surfacing and highway maintenance operations.  The Group employs over 3,500 people and has around 1 billion tonnes of mineral reserves and resources.  The Group's strategy is to continue growing through organic improvement and the acquisition of businesses in the heavyside construction materials market.

Enquiries:

Breedon Group plc Pat Ward, Group Chief Executive Rob Wood, Group Finance Director Robert Coates, Head of Investor Relations Cenkos Securities (NOMAD and Joint Broker to Breedon) Max Hartley Harry Hargreaves Numis Securities (Joint Broker to Breedon) Ben Stoop Heraclis Economides Teneo (Public Relations Adviser to Breedon) Matt Denham	01332 694010 07880 486329 020 7397 8900 020 7260 1000 020 7420 3180

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

ACQFIFIDFTLLIII